LakeShore Biopharma Co., Ltd.
PublicLakeShore Biopharma Co., Ltd. is now publicly traded
The data on this page reflects LakeShore Biopharma Co., Ltd.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
M&A
Nov 4, 2025
Est. Valuation at Exit
$37M
Total Funding Raised
$334M
Company Overview
LakeShore Biopharma Co., Ltd. is a biopharmaceutical company that discovers, develops, manufactures, and commercializes vaccines and therapeutic biologics for infectious diseases and cancer.
Sector
Healthcare
AI Layer
Non-AI
Keywords
LakeShore Biopharma Co., Ltd. Comparables
Compare LakeShore Biopharma Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shandong Yidu Biotechnology Co., Ltd. | 77% | |
| Jiangsu CuroVax Co., Ltd. | 57% | |
| Shanghai Qingsai Biotechnology Co., Ltd. | 52% |
LakeShore Biopharma Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Nov 4, 2025 | ||||
| Private Placement | Jul 8, 2025 | ||||
| Private Placement | Feb 9, 2024 | ||||
| M&A | Mar 16, 2023 | ||||
| PIPE | Mar 16, 2023 | ||||
Debt | Mar 16, 2022 |
LakeShore Biopharma Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Haitong International Securities Group | Series B |
| Hillhouse Investment | Series B |
| MSA Capital | Series B |
| F-Prime Capital | Series B |
| AIHC | Series B |
| HaiTong XuYu International Limited | Series A |
| CBC Group | Debt |
LakeShore Biopharma Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access